KELLY SCOTT: Open Payments
NPI 1043864572 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 14 payments from 8 companies in 2025. Trend: 2023 $843 · 2024 $550 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Amgen Inc. | 3 | $42 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| HEARTFLOW, INC. | 2 | $36 |
| Boston Scientific Corporation | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| PFIZER INC. | 1 | $18 |
Products named: REPATHA, VERQUVO, ENTRESTO, FFRct, BodyGuardian, JARDIANCE, CARDIOMEMS, VYNDAQEL.
Industry payments across TX — which companies pay providers there.
